Abstract
This Health Industry Insights report identifies and discusses initial insights obtained from Health Industry Insights' 2007 Personalized Medicine Payer Survey regarding the adoption of personalized medicine (PM) in the United States.
As an expansion of the concept of personalized medicine across the entire health industry value chain, personalized health impacts all market segments, including healthcare payers. Through their role in managing the financial component of healthcare delivery, payers are key stakeholders in the rate of adoption of personalized medicine solutions. This initial report looks at where payers are in the adoption of personalized medicine and how they gather insights on the approach and identifies some of the key drivers that influence how payers are responding to personalized medicine solutions arising from both the life sciences and healthcare providers.
"As personalized medicine initiatives are funded and adopted, healthcare payers face new challenges in balancing individual healthcare treatment best practices against legacy population-based and enterprise business models. Personalized medicine programs will have the same transformational affect on healthcare payers as the consumer driven health plan did, requiring changes and integration throughout healthcare payer business and technology models," said Janice Young, program director of Payer IT Strategies for Health Industry Insights.
Table of Contents
- Table of Contents
- Health Industry Insights Opinion
- In This Report
- Methodology
- Respondent Demographics
- Figure: Respondents by Organization Size
- Situation Overview
- Health Industry Insights' View of Personalized Medicine
- Payer Vision for Personalized Medicine
- Figure: Definition of Personalized Medicine
- Learning About Personalized Medicine
- Figure: Sources of Personalized Medicine Information
- Where Are We Today?
- Figure: Current Status and Progression of Personalized Medicine Technology Adoption
- Figure: Personalized Medicine Success Factors
- Figure: Key Stakeholders in the Shift Toward Personalized Medicine
- The Way Forward
- Targeted Therapeutics
- Figure: Key Factors Driving Targeted Therapeutics Reimbursement
- Figure: Willingness to Pay for Expensive New Targeted Therapeutics
- Figure: Consideration of Cost in the Drug Value Proposition
- Figure: Factors Driving Personalized Medicine-Based Diagnostic Testing
- Personalized Medicine-Based Diagnostics
- Figure: Key Factors Driving Reimbursement of Personalized Medicine-Based Diagnostic Testing
- Figure: Accelerating the Adoption and Growth of Targeted Therapeutics
- Implications
- Future Outlook
- Payer Expectations for Personalized Medicine
- Figure: Payer Hopes for Personalized Medicine
- Essential Guidance
- Actions to Consider
- Pharmaceutical Companies
- Diagnostics Companies
- Healthcare Technology Vendors
- Healthcare Payers
- Actions to Consider
- Learn More
- Related Research
- Synopsis
